Maithili Dalvi, Ph.D., Pmp Email & Phone Number

California, United States

Foster City, Ca, Us

🔹 Global commercial strategy & operations to support launch planning in the oncology therapeutic area.🔹 Project and process management of commercialization teams in achieving launch readiness.🔹 Thought partner to team leads and working with cross-functional global team from strategic marketing, medical affairs, market insights, value and access, and country affiliates.🔹 Development and tracking of work plans with key initiatives, milestones and deliverables.🔹 Optimization of process efficiency across teams and adapting methods to support dynamic business needs.

Sunnyvale, California, Us

1) Mentoring & People Development: I mentored a direct report and focused on his all round growth as a project and portfolio manager. Pls see the LinkedIn recommendation section for his experience and feedback.2) Portfolio Management: I managed the therapeutics portfolio across all disease areas and generated key metrics and analytics to aid in decision-making, project prioritization, and long-range planning. I established portfolio tools and capabilities and enabled visualization of key insights in dashboards. I led quarterly portfolio review meetings, and communicated with Project Leads, governance committees, and the Leadership team. Also supported Corporate Business Development in their efforts. Finally, I provided important portfolio highlights for Board of Directors meetings, Executive meetings and investor decks, and managed annual planning cycles for OKRs and the quarterly checks.3) Resource Management: I introduced this capability for the entire Therapeutics organization to enable better demand management and capacity planning. I spearheaded the selection and implementation of the software tool, and played both a strategic and hands-on role in building an integrated portfolio, project and resource management system.4) Project Management: I managed the advancement of multiple therapeutic programs to successful and timely decision points throughout target identification, target validation, drug discovery and drug development. I supported the Candidate Selection for the anti-CD96 antibody, leading to the very first IND filing and Phase 1 clinical program in the 23andMe and GSK collaboration.5) Alliance Management: I facilitated the collaboration with GSK through alliance management meetings, communication with scientific and business groups, contract management and issue resolution, and planning for joint governance meetings (research/development and steering committees).

Sunnyvale, California, Us

Sunnyvale, California, Us

I added value through strong scientific knowledge and diverse business skills. I played a very dynamic role in this early startup and enabled Drug Discovery through several activities — 🔸 Project Management🔸 Vendor Management🔸 Legal/Contracts & Intellectual Property Management🔸 Collaboration Management🔸 Finance & Accounting🔸 Competitive Intelligence🔸 Business Development & Strategy

Chicago, Illinois, Us

As a project manager and technical consultant, I provided corporate innovation leaders with the data and insight for driving product development and R&D planning decisions.🔹 Developed framework for addressing project goals.🔹 Managed teams and organized logistics using project management tools and software.🔹 Synthesized data into recommendations and presented results to clients.PROJECT HIGHLIGHTS:Project #1 (w/ oncology biopharma):- Analyzed preclinical and clinical landscape of new actionable targets in breast cancer.✔️Client was very impressed with the deliverables and initiated a longer-term project (Project #2, 1 year).Project #2 (w/ oncology biopharma):- Performed scientific, intellectual property, and competitive analysis of drug targets, presented results and addressed questions in client meetings.✔️Work led to a new target selection for the company's R&D pipeline and a 2nd contract renewal for additional 1 year.Project #3 (w/ engineering and product development company):- Delivered reports and presentations to clients on high-value topics through market research and financial analysis.✔️Client was very pleased with the work, resulting in renewal of the consulting contract for an additional 9 months.

Dallas, Texas, Us

I trained incoming interns (2 teams; 3-4 members each) and guided market research on newly patented biomedical technologies. By setting project expectations at the project kick-off meetings and evaluating progress in mid-project meetings, I was able to direct project focus and ensure that goals are met within the committed time.

Dallas, Texas, Us

As the 1st Vice President of the newly formed MitoGen Consulting Group, I was responsible for structuring multiple elements of pro bono consulting projects. I helped recruit project team members and drafted NDAs to ensure confidentiality. I advised a 7-member team in their project deliverables to the CEO of a biotech startup in Dallas. By communicating with the client post-project for feedback, I collected information for improving efficiency in future projects.

Dallas, Texas, Us

I demonstrated project leadership by spearheading the preclinical research efforts, and positioning the therapeutic target for clinical and commercial applications. I managed all project activities and interfaced with multiple cross-disciplinary teams (experimental biologists, computational biologists, medical oncologists, and intellectual property team).Outcome:- Authored a high-quality manuscript which was published in Cell Reports (2017).- Initiated a patent application through the University's Office for Technology Development (https://www.google.com/patents/WO2017190009A1?cl=en).Research Labs: John Minna, MD & Elisabeth Martinez, PhD

Dallas, Texas, Us

I reported to the former Director of Technology Licensing and acquired valuable knowledge in Market Research, Intellectual Property Management, Confidentiality, Material Transfer Agreements, Sponsored Research, Exclusive/Non-exclusive Licenses, and Negotiations.In my role, I assessed new invention disclosures for patenting, discussed new ideas with inventors on commercial positioning and developed a licensing strategy. I delivered a market research report and a marketing collateral highlighting the technology value proposition, and subsequently assisted in Business Development efforts by reaching out to companies for potential licensing.

Dallas, Texas, Us

My research work identified novel therapeutic targets for non-small cell lung cancers that develop resistance to standard taxane-platin chemotherapy (~60-70% of all chemotherapy-treated tumors). Chemoresistant cancer cells showed hyper-sensitization to JumonjiC demethylase inhibitors, JIB-04 and GSK-J4.- Formulated a research proposal and presented solutions for potential project pitfalls/risks.- Performed cell and molecular biology techniques, biochemistry, genomics, bioinformatics, and statistical analysis of experimental data.- Initiated and managed collaborations for access to expert knowledge and resources.- Presented work at meetings and conferences, and received best poster awards.- Was awarded membership of the esteemed scientific research society, Sigma Xi.- Wrote a first-author scientific manuscript for peer-reviewed journal submission.- Co-authored a review article on epigenetic anti-cancer therapies.

Dallas, Texas, Us

I was awarded a fellowship by The Howard Hughes Medical Institute, one of the largest private funding organizations for biological and medical research in the US. This gave me the opportunity to shadow medical oncologists at the Simmons Cancer Center on clinical rounds, learn about lung cancer treatment and interact with patients.I also received the HHMI travel grant for attending the Translational Science meeting in Washington D.C. I was honored with a ‘Scholars Abstract Award’ at this conference for fostering research through interdisciplinary team science.

Dallas, Texas, Us

I was 1 out of only 8 fellowship awardees selected from a class of 80+ candidates. This fellowship enabled me to gain a broad exposure to translational and clinical sciences through medical school courses in my PhD coursework. As a part of my training experience, I worked on a clinical research project, evaluating a novel method for the measurement of glomerular filtration rate in patients with renal disease. I handled patient databases and analyzed clinical data for this project.

Pune, Maharashtra , In

I was among the top 10 candidates selected for research at NCCS through a competitive application process. My Masters thesis project focused on paving the way for a new cell replacement therapy for Diabetes, a disease that affects over 400 million people in the world. I acquired scientific and technical knowledge in Stem Cell Biology and Epigenetics, and wrote a first-author review article for journal publication. As a part of wet lab research work, I studied histone modifications over the insulin gene in multiple tissues using chromatin immunoprecipitation (ChIP). I then performed epigenetic stimulation of human bone marrow-derived mesenchymal stem cells to induce them to differentiate into the endocrine lineage.

In

I was selected through a competitive application process to work at CCMB, a premier research organization. The fellowship was jointly awarded by 3 national science academies: Indian Academy of Sciences (IASc), Indian National Science Academy (INSA), and National Academy of Sciences, India (NASI).My research focus was on Glaucoma, the second leading cause of blindness, estimated to affect over 60 million people worldwide. I studied interactions of glaucoma associated mutants of Optineurin (Optic neuropathy-inducing protein) with optineurin-interacting partners using Yeast Two-hybrid assays, and delivered a thesis report to the sponsors.

Maharashtra, In

In this internship, I carried out molecular docking studies of pyrimidine derivatives as potent adenosine A2a receptor antagonists (which have broad therapeutic applications, including the treatment of Parkinson's disease and in cancer immunotherapy). I also performed quantitative structure-activity relationship studies (QSAR) of tetrahydro-beta-carbolines (neuroactive alkaloids found in chocolate) as monoamine oxidase enzyme inhibitors (indicated for the treatment of depression).

Credential Of Readiness (Core), Business Analytics, Financial Accounting, Economics

Certificate, Managing Science In The Biotech Industry

Doctor Of Philosophy (Phd), Cancer Biology

Master Of Science (Integrated Msc), Biotechnology